Filing Details

Accession Number:
0001179110-18-012090
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-09 14:20:16
Reporting Period:
2018-10-05
Accepted Time:
2018-10-09 14:20:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1522046 Beth Taylor 3000 Kent Ave, Ste A1-100
West Lafayette IN 47906
Vp Finance & Chief Acctg Offcr No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-10-05 7,022 $15.56 56,341 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the sale of 7,022 shares in a multiple transactions, ranging in price from $15.1300 to $15.9200, resulting in a weighted-average sale price per share of $15.5635. The 7,022 shares were sold to cover taxes, commissions and fees associated with the October 4, 2018 settlement of 15,000 restricted stock units in the form of Company common stock on a one-for-one basis. The shares were sold by Merrill Lynch pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934 adopted by the reporting person on July 30, 2018.